Sign Out
Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
First-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.
Treatment of advanced breast cancer in postmenopausal women with disease progression after tamoxifen therapy.
Continue with Google